Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
12
NCT00053716
Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 2003
Completion: Aug 31, 2003